Additionally, mogroside V (Table 4), the primary bioactive compound in Siraitia grosvenorii, a traditional Chinese medicinal plant, has been shown to upregulate SIRT1 expression and mitigate placental and pancreatic damage in GDM rat models [84]. This evidence concerns the gene SIRT1 and gestational diabetes.